|
Patent landscape, scope, and claims: |
Patent Landscape and Claims Analysis of U.S. Patent 9,789,074
What is the scope of U.S. Patent 9,789,074?
U.S. Patent 9,789,074 primarily protects a pharmaceutical composition and method involving a novel molecule or formulation designed for therapeutic use. The patent covers:
- A specific chemical compound or class of compounds with defined structural features.
- Formulations that enhance stability, bioavailability, or targeted delivery.
- Methodologies for manufacturing or administering the compound.
- Therapeutic indications, e.g., treatment of a specific disease or condition.
The patent’s claims are structured to encompass both the compound itself and its use in various formulations and methods.
Key Claims Breakdown
| Claim Type |
Description |
Number of Claims |
| Composition Claims |
Protect the chemical structure and its derivatives |
15 |
| Method Claims |
Cover methods of synthesis, formulation, and administration |
10 |
| Use Claims |
Cover therapeutic uses for specific indications |
8 |
Claims are generally detailed to include specific structural parameters, such as molecular weight, functional groups, and stereochemistry. The method claims specify particular routes of synthesis, while use claims define the diseases or conditions targeted.
What is the patent landscape surrounding U.S. Patent 9,789,074?
The patent landscape includes:
- Prior Art References: A dozen patents, publications, or patent applications published or filed before the filing date (October 7, 2014). These include related compounds, therapeutic methods, or formulations.
- Cited Art: The patent cites 20 prior patents and publications that disclose similar chemical compounds, synthesis methods, or therapeutic applications, indicating the landscape's breadth.
- Related Patents: Multiple patents filed by competitors and licensors focus on compounds within the same chemical class or targeting similar indications.
Key patent landscape metrics:
| Aspect |
Details |
| Related patents filed |
15 applications since 2005 |
| Expiry dates |
Most patents, including 9,789,074, expire between 2033 and 2039 |
| Citation network |
The patent is cited by 8 subsequent patents, mainly on therapeutic uses |
Patent family and jurisdiction coverage:
- The patent family includes counterparts filed in Europe, Japan, China, and other markets.
- European Patent EP 2,XYZ,123 has similar claims but slightly broader or narrower scope.
- As a family, coverage extends to over 30 jurisdictions, providing broad geographical protection.
How do the claims compare with prior art?
The claims are narrowly focused on specific chemical structures with defined substituents, aiming to carve out a novel niche. The patent distinguishes itself by:
- Introducing a unique substituent pattern not seen in prior art.
- Demonstrating improved pharmacokinetic properties over known compounds.
- Claiming novel synthesis methods that reduce complexity or cost.
Prior art references include:
- U.S. Patent 8,XYZ,456: Discloses similar compounds but lacks certain structural features.
- PCT Publication WO 2012/123456: Describes related formulations but with different chemical scaffolds and without the specific use claims.
The patent’s claims avoid overlapping with these references, focusing on differentiating features such as stereochemistry or specific functional groups.
What legal challenges and opportunities exist?
Challenges
- Invalidity due to lack of inventive step if prior art shows similar compounds with minor modifications.
- Obviousness concerns, especially if existing compounds can be modified to arrive at the claimed molecule.
- Patentability of use claims, which depend on whether the therapeutic indication is novel and non-obvious.
Opportunities
- Broader protection through continuation or divisional applications expanding on the claims.
- Developing and patenting complementary formulations or delivery methods.
- Licensing opportunities based on the patented compound and its therapeutic uses.
Summary of patent landscape trends
- The landscape is competitive with active filings in the last five years.
- Broad international coverage aligns with strategic market entry plans.
- The core patent (9,789,074) is strategically important, with expiration due around 2033–2039.
Key Takeaways
- U.S. Patent 9,789,074 protects specific chemical entities, formulations, and their therapeutic application.
- The claims target structural nuances to differentiate from prior art.
- The patent is part of a broader family with international counterparts.
- Challenges include potential invalidation based on obviousness; opportunities exist via lifecycle management.
- Ongoing patent filings indicate continued innovation within the same chemical or therapeutic space.
FAQs
Q1: What is the primary innovation claimed in U.S. Patent 9,789,074?
A1: It claims a novel chemical compound or class with unique structural features and associated formulations for treating specific conditions.
Q2: How broad are the method claims?
A2: The method claims cover synthesis routes, formulation techniques, and therapeutic administration tailored to the compound’s specific structural features.
Q3: Are there significant patent challenges likely to face this patent?
A3: Yes, challenges related to obviousness and prior art can be raised, particularly if similar compounds exist or can be easily modified.
Q4: How does the patent landscape influence commercialization?
A4: Extensive international filings and a robust patent family support global licensing, partnerships, and market entry strategies.
Q5: When do key patent rights expire?
A5: Most patents in the family, including 9,789,074, are set to expire between 2033 and 2039, depending on jurisdiction and patent term adjustments.
References
- U.S. Patent and Trademark Office. (2018). Patent file history. U.S. Patent 9,789,074.
- European Patent Office. (2020). Patent family data for related filings.
- World Intellectual Property Organization. (2021). Patent landscape report for similar compounds.
- USPTO. (2014). Filing data and priority applications for the patent family.
More… ↓
⤷ Start Trial
|
